michael f berger - genomic approaches to discover biomarkers of drug response in cancer
Published 10 years ago • 578 plays • Length 1:01:57Download video MP4
Download video MP3
Similar videos
-
1:05:01
discovery of biomarkers predictive of anticancer drug response in preclinical settings
-
34:57
mathew garnett: functional genomic approaches to guide cancer drug discovery
-
31:17
using genetic biomarkers for selection of targeted cancer therapies: pgx conference 2018
-
1:02:17
genomenon pharma webinar | genomic biomarker selection for companion diagnostic development
-
1:00:57
emma bowden - identification of predictive biomarkers from high throughput drug combination...
-
8:58
genomic biomarkers discovery
-
34:54
tumor immunoprofiling and the tumor microenvironment (immunotherapy documentary part ii)
-
1:47:32
genomics and personalized medicine
-
5:47
how biomarkers can improve the drug development process
-
30:46
"building a scalable genomics program" michael berger, 27.10.2021
-
10:03
an overview of comprehensive genomic profiling
-
51:59
thomas metcalfe-precision medicine approaches and the future of drug development in oncology
-
10:33
the germline genetic component of drug sensitivity in cancer... - michael menden - recomb/rsg 2015
-
0:57
empowering cancer treatment through personalized genomic sequencing
-
8:08
aacr 2013: genomic signatures and predictive biomarkers in breast cancer
-
17:34
prediction of cancer cell sensitivity to drugs based on... - michael menden - recomb/rsg 2012
-
37:03
sanger seminar - functional genomic approaches to guide cancer drug discovery - dr mathew garnett
-
0:45
immune checkpoint inhibitors: recent progress and potential biomarkers - 5i genetic signatures
-
1:01:03
michael holmes - evaluating biomarkers and therapeutic targets for cvd through human genetics
-
1:38:10
impact of genomics on cancer diagnosis and treatment part 2
-
33:15
the use of emerging genomic technologies to predict tumor response and drug resistance
-
1:18:32
advanced gi cancers: identifying and targeting uncommon but actionable genomic alterations